LONDON, Nov 25 (Reuters) – Conviction Life, an investor in diagnostic and pharmaceutical services technologies, has applied for an initial public offering for trading on the Main Market of the London Stock Exchange, the company said on Friday.
Conviction Life is targeting gross proceeds of up to £100 million (US$121 million) from the issuance of up to 100 million common shares.
The company will also conduct a placement program for up to 250 million common shares and plans to begin trading on December 16th.
($1 = 0.8263 pounds)
Reporting by Andres Gonzalez Editing by Mark Potter
Our standards: The Thomson Reuters Trust Principles.
Comments are closed.